TED Member States· European UniontenderOpen · 30 Oct 2026
Normal Human Immunoglobulin 10%
Detská fakultná nemocnica Košice
Deadline 30 Oct 2026Deadline30 Oct 2026
Estimated value€1,285,772
CPV category33651500
Published29 Sep 2026
Reference673851-2026
Notice summary
This medicine belongs to a group of medicines called intravenous immunoglobulins. These medicines are used to treat patients in situations where their defense (immune) system is not working sufficiently. The medicine is used for the treatment of: patients who do not have sufficient antibodies (replacement therapy) and patients with certain autoimmune diseases (immunomodulation).
Is this worth bidding on?
Tender Radar scores every tender against your company profile, surfaces the matching services, and flags the ones worth your time — across Europe and beyond. Sign in to see the relevance match and full AI analysis for this opportunity.